BIOSYNERGY INC: 10-Q filed 2011-12-15
What BIOSYNERGY INC reported in its quarterly report filed 2011-12-15 (fiscal Q2 2012): 22 published measures, 55 facts as tagged in accession 0000715812-11-000009.
This filing
- Form
- 10-Q (quarterly report)
- Filed
- 2011-12-15
- Fiscal period
- fiscal Q2 2012
- Accession
- 0000715812-11-000009 on SEC EDGAR
Values are as tagged in this filing. A later filing can restate them; a measure with a published history links to it, and the history shows the latest-filed value per period. All BIOSYNERGY INC filings.
Reported measures
Total assets
Resources recognized on the balance sheet. Book assets are not the market value of the business.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 1,158,253 | USD | |
| At 2011-04-30 | 1,102,387 | USD |
Stockholders equity
The reported residual interest after liabilities. It is an accounting amount, not market capitalization.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 1,063,372 | USD | |
| At 2011-04-30 | 1,012,037 | USD |
Cash and cash equivalents
Cash and qualifying short-term liquid investments under the filer’s accounting policy. Restricted cash and longer-term investments may be reported separately.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-04-30 | 667,897 | USD | |
| At 2010-04-30 | 426,569 | USD |
Net income or loss
Reported profit or loss for the period. Check the filing for attribution, exceptional items and discontinued operations before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 20,243 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 51,335 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 41,043 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 47,610 | USD | 184 |
Operating cash flow
Cash generated or used by operating activities. Working-capital timing can make this differ substantially from reported income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-10-31 | 63,757 | USD | 184 |
| 2010-05-01 to 2010-10-31 | 122,286 | USD | 184 |
Capital expenditure payments
Cash payments to acquire property, plant and equipment. This taxonomy concept does not capture every form of investment or acquisition.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-10-31 | 4,214 | USD | 184 |
| 2010-05-01 to 2010-10-31 | 7,495 | USD | 184 |
Investing cash flow
Net cash from investing activities, including asset purchases, disposals and investment transactions. This differs from capital expenditure payments alone.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-10-31 | -7,596 | USD | 184 |
| 2010-05-01 to 2010-10-31 | -16,577 | USD | 184 |
Retained earnings or deficit
Accumulated undistributed earnings or deficit at the reporting date. This balance is not cash available for distribution.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 422,083 | USD | |
| At 2011-04-30 | 370,748 | USD |
Income tax expense or benefit
Current and deferred income tax expense or benefit for continuing operations. This accounting expense differs from cash taxes paid.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 12,148 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 25,284 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 16,780 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 19,465 | USD | 184 |
Net property, plant and equipment
Carrying amount of property, plant and equipment after accumulated depreciation, depletion and amortization. It is not replacement cost or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 13,956 | USD | |
| At 2011-04-30 | 14,371 | USD |
Current assets
Assets classified as current under the normal operating cycle or one-year boundary. Not all current assets can be converted immediately into cash.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 984,049 | USD | |
| At 2011-04-30 | 930,622 | USD |
Current liabilities
Obligations classified as current under the operating-cycle or one-year boundary. The balance includes more than short-term borrowing.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 66,347 | USD | |
| At 2011-04-30 | 61,816 | USD |
Current accounts payable
Current amounts owed to suppliers for goods and services received. This is one component of current liabilities, not all accrued obligations.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 21,309 | USD | |
| At 2011-04-30 | 15,249 | USD |
Net current accounts receivable
Current customer receivables after the allowance for credit loss. The balance is not cash collected or a guarantee of collection.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 144,002 | USD | |
| At 2011-04-30 | 150,748 | USD |
Operating expenses
Recurring operating costs under this accounting concept, generally excluding production costs included in cost of sales. Check filing presentation before combining expense subtotals.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 175,682 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 356,055 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 144,477 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 332,943 | USD | 184 |
Gross profit
Revenue less the costs directly attributed to the goods or services sold. It precedes other operating expenses and is not net income.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 207,360 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 431,233 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 201,493 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 398,393 | USD | 184 |
Research and development expense
Research and development costs recognized as expense. Capitalization policies and acquired projects can make this differ from total cash invested in development.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 27,404 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 50,241 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 23,371 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 48,613 | USD | 184 |
Common shares outstanding
Common shares outstanding at the reporting date. This point-in-time count differs from the weighted-average shares used for earnings per share and can exclude other share classes.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-04-30 | 14,935,511 | shares |
Gross property, plant and equipment
Cost of property, plant and equipment before accumulated depreciation. Historical cost does not indicate current value or replacement cost.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 223,142 | USD | |
| At 2011-04-30 | 218,928 | USD |
Accumulated depreciation on property, plant and equipment
Cumulative depreciation, depletion and amortization recorded against property, plant and equipment. It measures cost allocation to date, not physical wear or market value.
| Period | Value | Unit | Days |
|---|---|---|---|
| At 2011-10-31 | 209,186 | USD | |
| At 2011-04-30 | 204,557 | USD |
General and administrative expense
General and administrative costs reported under this concept, separate from selling expense. Filers group overhead differently, so compare presentation before comparing companies.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-08-01 to 2011-10-31 | 108,481 | USD | 92 |
| 2011-05-01 to 2011-10-31 | 227,036 | USD | 184 |
| 2010-08-01 to 2010-10-31 | 86,525 | USD | 92 |
| 2010-05-01 to 2010-10-31 | 209,379 | USD | 184 |
Change in inventories
The cash flow adjustment for the change in inventories during the period. A positive value under this concept means inventory grew and reduced operating cash flow.
| Period | Value | Unit | Days |
|---|---|---|---|
| 2011-05-01 to 2011-10-31 | 13,437 | USD | 184 |
| 2010-05-01 to 2010-10-31 | -27,586 | USD | 184 |
Inspect the source
- Entity
- BIOSYNERGY INC / CIK 0000715812
- Captured
- SEC response SHA-256
eb912604535d1396c8e2ed6025c6adab35af75fdfc7239083d444e5a31df6a03
Current SEC company facts · Download the original response snapshot (gzip) · Download the selected JSON
Every published concept a filing tagged, with the periods it covered, as reported in that filing at capture time. Forms 10-K, 10-K/A, 10-Q, 10-Q/A, 20-F, 20-F/A, 40-F, 40-F/A. A filing page needs at least 8 published concepts. Later filings can restate these values; the company history pages show the latest-filed value per period.
Public company accounting reference, not market prices, returns, an investment recommendation, or ALPHAC performance. Validate a separately constructed return series with the validation API; accounting values are not returns.
Use this in research
A financial period ends before its results become public. Use the filing date as a minimum availability boundary, inspect amendments, and retain the original filing vintage when testing historical signals. This latest-filed selection can contain information unavailable at the time.
These pages do not supply prices, total-return histories, corporate-action adjustments or a tradable universe. Build those inputs separately before evaluating a strategy. A profitable backtest can still reflect selection bias or costs that were left out.
Research methodology · Execution and cost assumptions · Check backtest overfitting
Build with the open-source tools
Use these accounting records as inspectable inputs. When you have constructed a return series, the validation tools can help test its statistical evidence and preserve the result with its limitations.
- Get an API key and run your first validation
- Connect the MCP server to your coding assistant
- Inspect the ALPHAC engine on GitHub
- Read the MCP server source and integration examples
Read the published dataset with Python
import json
from urllib.request import urlopen
with urlopen("https://canlicapital.com/company-data/0000715812.json") as response:
record = json.load(response)
print(record["fetched_at"])
print(record["policy"])
for concept in record["concepts"]:
print(concept["tag"], next(iter(concept["observations"])))